By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Diffusion Pharmaceuticals 

2020 Avon Court, Suite 4

Charlottesville  Virginia  22902  U.S.A.
Phone: 434-220-0718 Fax: 434-220-0722


SEARCH JOBS


Industry
Pharmaceutical

Segment
Drug Discovery





Company News
Diffusion Pharmaceuticals To Present At Cavendish Global Health Impact Forum 10/30/2014 10:06:01 AM
Diffusion Pharmaceuticals Clinical Trial Of TSC In Brain Cancer Reaches One Year Interim Endpoint 5/15/2014 9:53:20 AM
Diffusion Pharmaceuticals Closes $5 Million Financing; Completes Enrollment and Dosing in Phase 2 Trial In Brain Cancer 6/20/2013 9:06:59 AM
Diffusion Pharmaceuticals Receives FDA Orphan Designation for TSC, a First-in-Class Drug for the Treatment of Metastatic Brain Cancer 12/11/2012 10:16:26 AM
Diffusion Pharmaceuticals Successfully Completes Phase I Brain Cancer Trial 11/20/2012 9:44:29 AM
Diffusion Pharmaceuticals Closes on $5 Million Financing; Continues Phase 2 Clinical Trial In Primary Brain Cancer 9/17/2012 10:20:25 AM
New Patents Issued to Diffusion Pharmaceuticals 8/16/2012 9:41:02 AM
Diffusion Pharmaceuticals Successfully Completes First Cohort in Multicenter Phase I/II Brain Cancer Trial of TSC 8/2/2012 10:39:58 AM
Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain Cancer 7/26/2011 9:24:21 AM
Diffusion Pharmaceuticals Achieves Positive Results in Phase I/II Clinical Trial of Trans Sodium Crocetinate in Peripheral Artery Disease 11/16/2010 11:41:04 AM
1234
//-->